Asclepion MCL31 Dermablate
Er:YAG Resurfacing · Er:YAG 2940nm fractional/full-field
The Asclepion MCL31 Dermablate typically sells new in the $70k–$100k range in the US, with used and refurbished systems around $25k–$45k. Asclepion MCL31 Dermablate holds FDA 510(k) clearance for its marketed indication. Figures are market estimates verified August 6, 2026.
What it's actually cleared for: Er:YAG coagulation, vaporization, ablation of skin (resurfacing)
Last verified: August 6, 2026 · How we verify
New: $70k–$100k|Used: $25k–$45kmarket estimate, no email required
| Manufacturer | Asclepion |
|---|---|
| Company | Not published |
| Category | Resurfacing, Tattoo & Vascular |
| Technology | Er:YAG 2940nm fractional/full-field |
| FDA status | FDA Cleared |
| New price range | $70k–$100k |
| Used price range | $25k–$45k |
| Consumables | Not published |
| Launch year | 2013 |
| Last verified | August 6, 2026 |
Overview
German erbium with thermal mode
FDA & regulatory status
What it's actually cleared for:
Er:YAG coagulation, vaporization, ablation of skin (resurfacing)
510(k) numbers
K150140
Regulatory data is compiled from public FDA 510(k) records and may lag recent clearances. Always confirm status with the manufacturer before purchase.
Treatment economics
Economics data for this platform hasn't been published yet.
Chains using this device
No confirmed chain deployments recorded yet.
Owner reviews
Write a reviewNo verified reviews yet — be the first. Founding reviewers get a thank-you gift card for an honest review, positive or negative. How verification works.
Alternatives
History
Every tracked change to pricing, lifecycle status, FDA data and warranty terms — newest first.
August 1, 2026
Record created
Added to The Aesthetic Index — August 2026
Source: The Aesthetic Index editorial
Get the full State of Aesthetic Devices 2026 report
The first full census of the US aesthetic device market — preview it free.